CastleVax
Michael Egan is currently the Acting CEO and Chief Scientific Officer at CastleVax. Prior to this role, Michael held leadership positions at various pharmaceutical companies including Aurobindo Pharma USA, AuroVaccines a Division of AuroPharma USA, Bill & Melinda Gates Medical Research Institute, Takeda, Profectus BioSciences, Inc, and Wyeth Research. Michael's educational background includes a Ph.D. in Immunology from The Johns Hopkins University School of Medicine and a B.S. in Chemistry from Northern Arizona University. Michael also served in the United States Marine Corps as a Corporal.
This person is not in any teams
This person is not in any offices
CastleVax
CastleVax is the proven technology that will bring safe vaccines for all humans, everywhere. Our state-of-the-art platform for producing first-in-class vaccines uses Newcastle Disease Virus (NDV) to enable rapid development of safe and highly immunogenic viral vectors that are easy to deliver and store, and can be administered via injection or intranasally.